Lille Model for Alcoholic Hepatitis
Predicts mortality in patients with alcoholic hepatitis not responding to steroid therapy.
The Lille Model risk stratifies patients already receiving steroids for alcoholic hepatitis treatment for 7 days to predict which will not improve and should be considered for other management strategies. All values besides 7-day bilirubin are taken from admission.
Result:
Philippe Mathurin, MD, PhD, is professor of hepatology and head of the research program on liver disease in the Department of Hepatology and Gastroenterology at the University Hospital of Lille, France. He has been an associate editor of the Journal of Hepatology since 2009. Dr. Mathurin has published extensively on research topics including alcoholic liver disease, viral hepatitis, non alcoholic fatty liver disease and hepatocellular carcinoma.